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Abstract
The causes of the current global decline in honey bee health are unknown. One major group of hypotheses invokes the
pesticides and other xenobiotics to which this important pollinator species is often exposed. Most studies have focused on
mortality or behavioral deficiencies in exposed honey bees while neglecting other biological functions and target organs.
The midgut epithelium of honey bees presents an important interface between the insect and its environment. It is
maintained by proliferation of intestinal stem cells throughout the adult life of honey bees. We used caged honey bees to
test multiple xenobiotics for effects on the replicative activity of the intestinal stem cells under laboratory conditions. Most
of the tested compounds did not alter the replicative activity of intestinal stem cells. However, colchicine, methoxyfenozide,
tetracycline, and a combination of coumaphos and tau-fluvalinate significantly affected proliferation rate. All substances
except methoxyfenozide decreased proliferation rate. Thus, the results indicate that some xenobiotics frequently used in
apiculture and known to accumulate in honey bee hives may have hitherto unknown physiological effects. The nutritional
status and the susceptibility to pathogens of honey bees could be compromised by the impacts of xenobiotics on the
maintenance of the midgut epithelium. This study contributes to a growing body of evidence that more comprehensive
testing of xenobiotics may be required before novel or existing compounds can be considered safe for honey bees and
other non-target species.
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Introduction
The western honey bee, Apis mellifera (L), is the most important
managed pollinator worldwide and provides economically impor-
tant pollination services in natural and agricultural ecosystems
[1,2]. Despite their significance to agriculture, the number of
managed honey bee colonies in the United States has declined
over the past decades [3]. Since 2006, severe annual losses have
been reported by beekeepers in conjunction with declining honey
bee health and a syndrome of collapsing colonies that accounts for
some of these losses [4,5]. This colony collapse syndrome is
characterized by the rapid disappearance of adult worker honey
bees, arguing for research on adult honey bee health.
The causes of the observed decline in honey bee health are
poorly understood [5,6]. Presumably, these causes are complex
and heterogeneous with multiple, potentially interacting contrib-
utors [7,8,9]. Novel pathogens such as Israeli acute paralysis virus
and combinations of parasites and pathogens have been associated
with declining honey bee health in laboratory studies [10] and
large-scale surveys [11,12]. General management stress reflecting
changes in beekeeping practices and inadequate nutrition may also
play important roles [13,14]. Additionally, pesticides and other
xenobiotics have been associated with mass killings of honey bees
[15], and novel compounds, formulations, and applications may
contribute to recent declines in honey bee health [16,17,18].
Honey bees are exposed to a large number of xenobiotics, some
of which accumulate in their hives [16,18]. Over 120 pesticides
and metabolites have been identified to enter the hive with
returning foragers or as a result of direct application by beekeepers
[19,20]. This large number is concerning because substances can
harm honey bee health via synergistic interactions [16,21,22].
Modern systemic insecticides are incorporated into all plant parts,
including the pollen and nectar that honey bees collect [23].
Through food-storage and -sharing these substances are distrib-
uted throughout the hive although substances that are directly
applied to the hive, such as the miticides coumaphos and
fluvalinate, are typically found in higher concentrations
[18,21,24].
Field-relevant concentrations of some pesticides not only kill
honey bees but also produce sublethal effects detectable as
behavioral deficiencies [25,26,27,28], shortened lifespan [29,30],
or increased susceptibility to diseases [8,31,32]. Because many
pesticides target the nervous system, tests of sublethal effects on
honey bees have concentrated primarily on behavior and direct
measures of neuronal activities [33,34]. Sublethal effects on other
functions and organs have been rarely studied, although pesticides
and other xenobiotics are known to affect several physiological
functions. For example, compromised hypopharyngeal gland
development caused by exposure of nurse bees to four different
pesticides [35] can be linked to decreased brood production at the
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colony level [36]. Exposure of the midgut epithelium of honey bee
larvae to sublethal concentrations of a broad range of pesticides
resulted in increased apoptosis [37]. Both of these observations
predict smaller colony sizes that eventually translate into reduced
colony survival [38]. Neither of these studies, however, directly
addresses the topic of sublethal physiological effects in adult
workers. This gap in the literature is significant given a context of
colony collapse without reduced brood production [9].
The digestive system is a critical organ for honey bee health
because it is the site of contact with many pathogens and
xenobiotics [39,40]. The midgut epithelium is for many pathogens
the principal barrier to invasion of the honey bee host, and it is the
main site for establishment of other pathogens, such as Nosema sp.
[41]. Additionally, the midgut epithelium is responsible for
detoxification of ingested xenobiotics [42], and some insecticides
specifically target the midgut epithelium [40,43]. Damage to the
midgut epithelium of honey bees has also been reported as a
consequence of acute exposure to the insecticides malathion,
deltamethrin, and thiamethoxam [44]. This spatial overlap
between immunity and detoxification may facilitate synergistic
interactions between pesticides and pathogens to the detriment of
honey bee health [7,39].
The midgut epithelium is the only tissue of adult honey bees
that exhibits widespread cell proliferation [45]. Proliferation also
occurs in the midgut of stingless adult bees, although at a lower
rate than reported for honey bees. [46]. Proliferative cells (Figure 1)
continuously replace the columnar and goblet cells that form the
functional epithelium [47,48,49]. The proliferative activity of the
intestinal stem cells (ISCs) varies with age and social function and
responds dynamically to high digestive activity [45,50]. The
proliferation rate of the ISCs could therefore be a sensitive
indicator of sublethal effects of ingested xenobiotics in the honey
bee. On the one hand, toxic effects may increase the rate of
proliferation by increasing the demand for cellular replacement. If
replicative capacity of the ISCs is unable to compensate, epithelial
function may be compromised and lifespan may be shortened. On
the other hand, toxins may directly damage the ISCs, directly
resulting in a decreased proliferation rate which may also
compromise epithelial function and shorten lifespan.
We have examined the impact of a number of pesticides and
other xenobiotics on ISC proliferation in honey bees. To
investigate this potential mode of xenobiotic action, we used
relatively high doses in a controlled cage environment. We
concomitantly monitored survival but our focus was on the
question of whether ISC proliferation is altered by sublethal
exposure to common xenobiotics.
Materials and Methods
Experiment 1
Ten xenobiotics were studied along with solvent controls
(Table 1). We used colchicine, an inhibitor of mitosis [51], as a
control to demonstrate that our method was sensitive enough to
detect the inhibition of ISC proliferation by a xenobiotic [45]. The
insect steroid 20-hydroxyecdysone was selected as a positive
control because of previous reports of a positive effect of this
hormone on ISC proliferation in other insect species [52]. The
trials involved monitoring survival during continuous exposure to
one concentration of each xenobiotic over seven days, followed by
a standardized assessment of intestinal stem cell proliferation. The
chosen concentrations either represented the maximum concen-
trations reported from bee hives in the literature or, in the case of
compounds typically applied to colonies by beekeepers, the
maximum allowable dose per manufacturer instructions.
Workers (Apis mellifera L) from 4–10 hives maintained at the
University of North Carolina at Greensboro bee yard were used.
Colonies were maintained following standard practices without
chemical disease control or artificial diets. Combs with ready-to-
emerge workers were transferred to an incubator (complete dark
cycle, 35uC, 60% rel. hum.) and collected from the combs upon
emergence. Newly emerged bees were randomly assigned to
treatment or control groups. Four groups of 25 bees per treatment
were kept in separate Plexiglas feeding cages (10 cm67.5 cm
610 cm) in an incubator (complete dark cycle, 33uC, 60% rel.
hum.), fed ad libitum queen candy (9:3:1, powdered sugar: water:
honey), and provided with water. Dead bees were removed and
counted from the cages daily. Although cage studies are widely
used in honey bee research [53], they can be problematic [54] and
have been reported to compromise the natural colonization of the
gut by bacteria [55]. We preferred the controlled cage environ-
ment for these initial studies because our goal was to link a known
xenobiotic exposure to quantitative effects on ISC proliferation.
All substances except tau-fluvalinate were mixed with the queen
candy food for direct delivery to the midgut epithelium. Tau-
fluvalinate was delivered via Apistan strips (Zoëcon, USA), the
form typically used by beekeepers. Two of the four tau-fluvalinate
cages were terminated after three days instead of the planned
seven day exposure to ensure that a sufficient number of living
honey bees could be obtained for our studies of ISC proliferation.
For all other treatments, living honey bees were collected from the
cages after seven days for ISC proliferation assays.
Experiment 2
On the basis of the results of the first experiment only
methoxyfenozide, tetracycline, and tau-fluvalinate were tested
further in large scale studies, using three different dosages
(Table 2). Because of the potential for synergistic effects [22], a
combination of tau-fluvalinate and coumaphos was also tested.
The experiment comprised eleven trials, each with its own water
Figure 1. Cross section of the honey bee midgut, showing the
midgut epithelium consisting of discrete crypts. The peritrophic
membrane is visible in the midgut lumen. In the midgut epithelium,
BrdU-labeled nuclei are brown, indicating that DNA replication occurred
during the 24 h exposure to the marker. An index of proliferative
activity has been developed based on counting the number of labeled
nuclei in 10 mm thick cross sections relative to the number of active
crypts. This index can be used to rank proliferative activity in different
samples and assess possible sublethal effects of ingested xenobiotics
on the midgut epithelium. Sections are counterstained with hematox-
ylin (in blue) to facilitate detection of crypts and other tissue features.
doi:10.1371/journal.pone.0091180.g001
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or acetone control groups to account for seasonal effects and the
use of honey bees from different sources. As described, newly
emerged bees were caged, housed in an incubator, and fed
xenobiotics in food provided ad libitum for seven days. In this study,
food was provided as a 30% sucrose solution in liquid feeders.
Two-four replicate cages were used per treatment, with 120–155
bees housed per cage (same dimensions as in Experiment 1).
Survival was monitored daily, and a subset of the surviving bees
assayed for ISC proliferation after 7 days (see below). Fresh and
dry weights of the head and thorax of random samples of
additional bees from all treatments were determined to test for
differences in food uptake.
After the collection on day 7, the remaining honey bees were
continued to be daily monitored for survival in their cages without
xenobiotic exposure: They were provisioned with distilled water
and sucrose solution. A second sample of honey bees of each
treatment group was assayed for delayed treatment effects on ISC
proliferation between ages 19–22 days, or earlier if mortality of the
experimental cohort exceeded 90% before that age.
ISC Proliferation Assay
Following our previous methods [45,50], assessment of prolif-
eration rate of intestinal stem cells relied on immunohistochemical
labeling of the thymidine analog 5-bromo-2-deoxyuridine (BrdU)
incorporated into newly synthesized DNA. Briefly, workers
without signs of morbidity such as reduced mobility or respon-
siveness to stimuli were selected for this assay. These individuals
were fed 5 mg/ml BrdU (Life Technologies, CA) in queen candy
ad libitum for a 24-hour period. Shorter feeding periods were
evaluated in a pilot study with newly emerged workers (Figure 2),
and a 24-hour period was selected for the actual experiments
because this survival reliably produced a substantial number of
labeled nuclei.
Only individuals that appeared healthy after this feeding period
were selected for analysis. Dissected midguts rinsed with saline
were fixed in Carnoy’s fixative for 24 hours and embedded in
Paraplast (Thermo Fisher Scientific, MA) for sectioning (10 mm)
using a HM315-Microm microtome (Thermo Fisher Scientific,
MA). Sections were mounted on Superfrost Fisher plus microscope
slides (Thermo Fisher Scientific, MA), dewaxed in xylene,
rehydrated via a graded alcohol series, and permeabilized in
phosphate-buffered saline containing 0.01% Triton X-100 deter-
gent (PBS-T; Sigma-Aldrich, MO). Samples were denatured with
2N hydrochloric acid, washed in phosphate-buffered saline (PBS),
blocked with normal goat serum (Thermo Fisher Scientific, MA),
and incubated with anti-BrdU antibody (Phoenix Flow Systems,
Table 1. Xenobiotics tested in the first experiment for effects on the intestinal stem cell proliferation.
Xenobiotic Supplier Dosage Source for selecting concentrations
Fumagillin Mann Lake Ltd 2 mg/g Highest dose allowed per manufacturer guidelines
Tau-fluvalinate* Mann Lake Ltd Permanent exposure Practical dosage under experimental conditions exceeds manufacturer
guidelines
Tetracycline Sigma- Aldrich 3 mg/g [60]
Imidacloprid Sigma-Aldrich 500 ppb [16]
Coumaphos Sigma-Aldrich 5000 ppb [16]
Chlorothalonil Fluka 1000 ppb [16]
Methoxyfenozide ChemSevice Inc. 400 ppb [16]
Colchicine Sigma-Aldrich 5 mg/g [51]
20-Hydroxyecdysone MP Chemicals 200 ppb [68]
DMSO Acros Chemical 0.01 mg/g Control for imidacloprid
Acetone Mallinckrodt Chemicals 0.1 mg/g Control for methoxyfenozide, coumaphos, and chlorothalonil
Isopropanol Fisher 200 ppb Control for 20-hydroxyecdysone
Water N/A N/A Control for tetracycline, colchicine, tau-fluvalinate, and fumagilin
* Tau-fluvalinate was exposed to bees using the commercial Apistan strip. A half of one standard strip was placed in each cage for the indicated exposure time per day
for 7 days.
doi:10.1371/journal.pone.0091180.t001
Table 2. Summary of the second experiment testing different dosages of select xenobiotics for effects on intestinal stem cell
proliferation.
Xenobiotic Supplier Dosage
Low Mid High
Methoxyfenozide ChemSevice Inc. 40 ppb 400 ppb 2000 ppb
Tau-fluvalinate* Mann Lake Ltd 3 minutes randomized 3 minutes sequential 15 minutes
Tetracycline Sigma-Aldrich 1.2 mg/g 30 mg/g 60 mg/g
Tau-fluvalinate* and 500 ppb Coumaphos Mann Lake Ltd Sigma-Aldrich 3 minutes randomized 3 minutes sequential 15 minutes
* Tau-fluvalinate was exposed to bees using the commercial Apistan strip. A full strip was placed in each cage for the indicated exposure time per day for 7 days.
doi:10.1371/journal.pone.0091180.t002
Xenobiotics and Honey Bee Intestinal Stem Cells
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e91180
PRB1U) for 24 h at 4uC. After several washes in PBS-T and PBS,
sections were incubated at room temperature for two hours with a
peroxidase-conjugated anti-mouse secondary antibody (Jackson
ImmunoResearch Laboratories, PA), washed again, and incubated
with the chromogen diaminobenzidine (Sigma-Aldrich, MO). All
nuclei containing DNA synthesized after ingestion of BrdU were
labeled with a dark brown reaction product. Slides were
counterstained for approximately five minutes using Gill hema-
toxylin (Thermo Fisher Scientific, MA) followed by 0.1% sodium-
bicarbonate solution for one minute. After dehydration in ethanol,
the tissue was cleared with CitriSolv (Thermo Fisher Scientific,
MA). Slides were coverslipped using Permount and viewed under
a Nikon Eclipse E200 microscope.
In the first experiment, all BrdU-labeled nuclei and active
centers of proliferation (crypts) were counted in one randomly
selected intact section per individual (Figure 1). An active crypt
was defined as any containing one or more cells with a labeled
nucleus. The average number of labeled nuclei per crypt visible in
the selected section was calculated. In the second experiment, the
labeled nuclei of 10–22 random crypts from multiple, arbitrarily
selected intact cross sections were counted, and the average
number of labeled nuclei per crypt was determined to reduce bias
associated with analysis of a single section. Observers evaluated
slides without knowledge of treatment group identity.
Analyses
In the initial screening experiment, differences in survival
between xenobiotic exposed-groups and control groups were
assessed by simple contingency analyses with Yates’ correction
because standard survival estimates and statistical comparisons
could not be computed in groups with 100% survival until the end
of the experiment. In the follow-up experiments, survival was
compared among the treatment and vehicle control groups by
pairwise Kaplan-Meier analysis (log-rank tests), censoring any
individuals that were sampled for quantification of their intestinal
stem cell proliferation or weight determination. We separately
assessed acute mortality (during xenobiotic exposure) and legacy
mortality (after xenobiotic exposure was terminated). Cages were
treated as separate replicates in the overall evaluation of each
experimental treatment.
In the first experiment, the effects of each xenobiotic on the
number of labeled nuclei, active crypts, and number of labeled
nuclei per crypt were assessed by simple ANOVAs. In the second
experiment, the effect of each xenobiotic on the number of labeled
nuclei per crypt was analyzed by ANOVA using age group (acute
versus legacy effects) as one independent fixed factor and
treatment as the second factor. The treatment factor divided the
samples into honey bees that were exposed to the three different
concentrations of each xenobiotic and the appropriate vehicle
control. The overall analyses were followed by separate analyses of
the two age groups in which interactions between treatment and
age were indicated. Because of unequal variances among groups,
post hoc comparisons among the different doses of a specific
xenobiotic treatment were performed with Dunnett’s T3 test.
Results
Experiment 1
ISC proliferation was significantly affected by feeding on
colchicine, tetracycline, and methoxyfenozide, but not by feeding
on fumagilin, imidacloprid, coumaphos, chlorothalonil, or by
fluvalinate treatment (Table 3). Compared with untreated
controls, colchicine significantly reduced the number of labeled
nuclei per active crypt (2.8 versus 4.7). Workers that fed on
tetracycline had fewer active crypts per section (32.8 versus 55.3),
fewer labeled nuclei per section (55.9 versus 254.9), and fewer
labeled nuclei per active crypt (1.7 versus 4.7). In contrast,
methoxyfenozide significantly increased labeled nuclei per section
(324.9 versus 251.5) and per crypt (5.3 versus 4.7), relative to
controls (Figure 3). The survival of individuals across experimental
groups was positively correlated with the average number of
labeled nuclei per crypt (Pearson’s RP = 0.79, n = 13, p = 0.001).
The proportion of surviving individuals varied among experimen-
tal groups from 6.4% to 100%. None of the solvent controls
affected honey bee survival but survival was significantly reduced
by the high experimental exposure to colchicine (x2 = 154.7,
p,0.001), tetracycline (x2 = 169.2, p,0.001), fluvalinate (x2 =
119.2, p,0.001), fumagillin (x2 = 76.4, p,0.001), imidacloprid
(x2 = 20.9, p,0.001), and coumaphos (x2 = 6.4, p = 0.012) relative
to their respective controls.
Experiment 2
The experimental groups did not differ significantly in fresh or
dry weights of the head (Ffresh(9,379) = 1.4, p = 0.167,
Fdry(9,379) = 1.2, p = 0.267) or dry weight of the thorax
(Fdry(9,379) = 1.3, p = 0.218). In contrast, thorax fresh weight was
significantly affected (Ffresh(9,379) = 2.5, p = 0.010). Post hoc compar-
isons revealed that a significantly lower thorax weight was found in
the acetone control group than in the water control and in the
highest tetracycline dosage group.
Xenobiotic feeding effects on the number of labeled nuclei per
active crypt were variable (Figure 4). Tetracycline showed
significant concentration (F(3,99) = 2.8, p = 0.042), age group
(F(1,99) = 18.5, p,0.001), and interaction (F(3,99) = 2.9, p = 0.040)
effects. Overall, sections contained more labeled nuclei directly
after termination of treatment than two weeks later. Differences
among treatments were not significant in the young age group
directly after xenobiotic exposure (F(3,57) = 2.4, p = 0.081), but the
highest dosage of tetracycline was associated with a significant
Figure 2. The number of labeled nuclei in a single midgut
cross-section is a function of duration of exposure to BrdU. This
presumably reflects the number of cell cycle events that occur during
the exposure. To control for this effect, a standardized 24 h duration of
exposure to BrdU via feeding was used in the main experiments that
assessed the effects of xenobiotics on intestinal stem cell proliferation.
The longer exposure time is also expected to increase the accuracy of
ISC proliferation estimate, although the inter-individual variation
among samples in this experiment was lower after 8 and 12 h.
doi:10.1371/journal.pone.0091180.g002
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decline in the number of labeled nuclei per crypt compared with
the control group in the older age group (F(3,42) = 3.5, p = 0.025).
Analysis of the results of the methoxyfenozide experiment revealed
a smaller number of labeled nuclei in older bees (F(1,71) = 29.0,
p,0.001), no overall effect of treatment (F(3,71) = 1.1, p = 0.349),
but a significant interaction between the two factors (F(3,71) = 3.5,
p = 0.019). Analyzed separately, no significant effect of treatment
was apparent in either age group (young: F(3,34) = 2.5, p = 0.074;
old: F(3,37) = 1.4, p = 0.250). Fluvalinate alone exhibited no overall
age group (F(1,98) = 2.3, p = 0.129) or treatment (F(3,98) = 1.1,
p = 0.371) effects but a significant interaction effect (F(2,98) = 3.1,
p = 0.048). Separate analyses did not reveal specific treatment
effects in either age group (young: F(3,57) = 2.3, p = 0.087; old:
F(2,41) = 0.5, p = 0.616). Coumaphos and fluvalinate in combina-
tion showed a significant treatment effect (F(3,58) = 6.8, p = 0.001),
no age group effect (F(1,58) = 3.1, p = 0.084), and a significant
interaction between the two factors (F(2,58) = 4.0, p = 0.023).
Treatment significantly affected the labeled nuclei per active crypt
in the younger group (F(3,30) = 7.8, p = 0.001), with the highest
dosage significantly reducing the counts relative to the control and
lowest dosage. In the older group, no significant treatment effect
was found (F(2,28) = 1.0, p = 0.385).
Across all treatment groups, there was no significant relation
between ISC proliferation directly after xenobiotic exposure and
its measure at older ages (Rs = 0.02, n = 13, p = 0.943). The
average ISC proliferation in the groups sampled at the older age
was positively associated with survival after treatment (RS = 0.67,
n = 13, p = 0.013), while no association between ISC proliferation
and survival at the younger age (during xenobiotic exposure) was
found (RS = 20.19, n = 15, p = 0.499).
Mortality in the caged experimental cohorts was generally
higher than in the first experiment with seven-day survival ranging
from 44–68% and significant variation among cages of the same
treatment groups, including control groups (see File S1). Overall,
the acute mortality was different among treatment groups for
tetracycline (x2 = 10.1, p = 0.018; Figure 5a), methoxyfenozide
(x2 = 8.8, p = 0.032; Figure 5b), fluvalinate (x2 = 18.7, p,0.001;
Figure 5c), and the combination of fluvalinate and coumaphos
(x2 = 38.9, p,0.001, Figure 5d). After Bonferroni correction, only
the 3-minute fluvalinate treatment (x2 = 11.8, pcorr = 0.002) and
the 3-minute fluvalinate exposure combined with coumaphos
(x2 = 31.0, pcorr,0.001) increased mortality compared with the
respective solvent controls.
Overall legacy mortality after the treatment was different
among experimental groups for tetracycline (x2 = 113.6, p,0.001;
Figure 5a), fluvalinate (x2 = 27.3, p,0.001; Figure 5c), and the
combination of fluvalinate and coumaphos (x2 = 114.4, p,0.001,
Figure 5d). Treatments that significantly increased legacy mortal-
ity relative to their respective controls were the medium (x2 = 32.5,
pcorr,0.001) and high (x
2 = 33.7, pcorr,0.001) dose of tetracycline
and the 361 min exposure of fluvalinate (x2 = 11.5, pcorr = 0.002).
Discussion
This study demonstrated that select xenobiotics can decrease
the proliferative rate of ISCs of adult worker honey bees. Reduced
ISC proliferation represents a novel, possibly important effect of
xenobiotics because the midgut epithelium provides the first line of
defense against many pathogens, is responsible for nutrient uptake,
and detoxifies many ingested toxins [39].
Most of the tested substances did not significantly affect ISC
proliferation although they were directly ingested and therefore
must have come into close contact with the midgut epithelium of
the studied honey bees. This finding contrasts with widespread
pesticide effects on apoptosis in the midgut of honey bee larvae
[37], suggesting that juvenile stages might be more susceptible to
pesticides than adults. Only colchicine (included as a technical
Figure 3. In the first experiment, 3 of the 12 xenobiotics tested
had significant effects on the number of labeled nuclei per
active crypt. While colchicine and tetracycline decreased the
proliferation of ISCs, methoxyfenozide increased activity. Means are
shown with 95% confidence intervals.
doi:10.1371/journal.pone.0091180.g003
Table 3. Xenobiotic feeding effects* on ISC proliferation pooled across replicate cages.
Xenobiotic Effect on # of labeled cells per cross-section Effect on # of crypts per cross-section Effect on # of labeled cells per crypt
Fumagillin F(1,17) = 0.0, p = 0.936 F(1,17) = 0.0, p = 0.900 F(1,17) = 0.4, p = 0.536
Tau-fluvalinate F(1,31) = 0.0, p = 0.946 F(1,20) = 0.2, p = 0.626 F(1,20) = 1.8, p = 0.195
Tetracycline F(1,14) = 56.3, p,0.001 F(1,13) = 17.7, p = 0.001 F(1,13) = 56.3, p,0.001
Imidacloprid F(1,16) = 0.0, p = 0.983 F(1,16) = 0.0, p = 0.871 F(1,16) = 0.0, p = 0.967
Coumaphos F(1,19) = 0.6, p = 0.440 F(1,17) = 0.2, p = 0.678 F(1,17) = 3.2, p = 0.091
Chlorothalonil F(1,23) = 0.4, p = 0.544 F(1,20) = 0.1, p = 0.725 F(1,20) = 0.8, p = 0.384
Methoxyfenozide F(1,21) = 6.9, p = 0.016 F(1,20) = 3.4, p = 0.079 F(1,20) = 4.4, p = 0.049
Colchicine F(1,11) = 4.2, p = 0.065 F(1,9) = 0.4, p = 0.534 F(1,10) = 7.2, p = 0.025
20-Hydroxyecdysone F(1,20) = 0.3, p = 0.592 F(1,18) = 1.3, p = 0.273 F(1,18) = 0.3, p = 0.596
*Significant effects in bold.
doi:10.1371/journal.pone.0091180.t003
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control), tetracycline, methoxyfenozide, and a combination of
fluvalinate and coumaphos showed effects on ISC proliferation.
The effects were moderate, dose-dependent, and inconsistent
between experiments for methoxyfenozide. Our overall results
indicate that the replication rate of ISCs is quite robust after
ingestion of most xenobiotics under cage conditions. In contrast,
in-hive studies have shown that ISC replication rates decrease in
worker honey bees with age and reduced digestive activity [45,50].
Future experiments that better mimic hive conditions and field-
relevant exposure levels will be necessary to assess the threat of
xenobiotics for intestinal health of honey bees.
Xenobiotic-induced alteration of ISC proliferation may directly
harm the affected worker honey bees, causing an increase in
immediate or delayed mortality. Overall, our results suggest that
reduced ISC proliferation is associated with mortality. Specifically
in the second experiment, one of the coumaphos and fluvalinate
combination treatments decreased ISC proliferation and survival
during exposure; the high tetracycline dosage exhibited delayed
effects on both ISC proliferation and mortality. Under field
conditions, these effects would result in smaller and/or collapsed
colonies due to increased mortality of adult workers. However, we
cannot rule out that xenobiotic-induced alteration of ISC
proliferation also occurs independently of increased mortality.
Under field conditions such effects may increase individual disease
susceptibility, for example to Nosema [7,56], and compromise the
physiological capacity of nurse bees to produce sufficient brood
food. Additional studies are needed to address these questions
because exposures to sublethal levels of xenobiotics are likely to be
more common than exposures to lethal levels [32,38] and
sublethal effects are important but difficult to integrate into
pesticide regulation [33,57].
In the first experiment, mortality in the cages was increased by
several xenobiotics presented at high dosages. Therefore, we
employed lower dosages in the second experiment and extended
our mortality and ISC proliferation measurements to include
potentially subtle long term effects on ISC proliferation. The
sample sizes required for the additional long term analyses resulted
in crowded cages and higher mortality, even in the untreated
control cages. The increased mortality likely reflects a variety of
factors, including poorer hygiene and competition for access to the
feeder [53]. However, the determination of worker body weight at
the end of the second experiment did not indicate significant
differences in food intake between xenobiotic and control groups.
We excluded all moribund individuals when assessing ISC
proliferation but the concomitant assessment of potential mortality
effects of the administered treatment is problematic, particularly
because significant variation among replicate cages existed and
effects on mortality were inconsistent when cages were analyzed
separately (see File S1). Thus, we are reluctant to label any of the
measured effects as lethal or sublethal, although mortality was
increased by treatments that reduced ISC proliferation. Similarly,
the insecticides thiamethoxam, deltamethrin, and malathion have
been shown to disrupt the integrity of the honey bee midgut at
concentrations that increase mortality [44].
Tetracycline is widely used by beekeepers to combat Paenibacillus
larvae and Melissococcus plutonius, the bacterial agents of American
and European foulbrood, respectively [58], but it is a general
antibiotic with a wide range of target microorganisms [59].
Compared with controls, caged honey bees exposed to tetracycline
exhibited lower ISC proliferation in both experiments. In the first
experiment, a dosage that was 1000-fold higher than that typically
found in hives [60] significantly reduced ISC proliferation directly
after the seven days of treatment. In the second experiment a 50-
fold reduced dosage, but not a 100-fold or 2500-fold reduced
dosage, also reduced ISC proliferation in the long term. No short-
term effects were observed for the lower dosages in the second
experiment. Thus, exposure of honey bees to very high doses of
tetracycline may result in acute deterioration of the gut physiology
Figure 4. ISC proliferation, indicated by the number of BrdU-labeled nuclei per active crypt, was significantly decreased in older
bees. The combination of coumaphos and fluvalinate reduced proliferation measured immediately after treatment, while tetracycline decreased
proliferation only at older ages, over ten days after exposure to the xenobiotic had ended.
doi:10.1371/journal.pone.0091180.g004
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or compromise ISCs directly, while lower concentrations of
tetracycline appear to produce a delayed effect. The delayed
effect could be due to changes in the intestinal microbial
community that can disrupt honey bee health [61,62]. Although
we did not monitor the intestinal microbiome, our results could be
explained by an interaction between the intestinal microbiome and
the physiology of its honey bee host, similar to findings reported in
Drosophila that linked the intestinal microbiome to stem cell
proliferation [63].
The insect growth regulator methoxyfenozide has not been
demonstrated to be harmful to adult honey bees [64], but this
compound also accumulates in honey bee hives at significant
concentrations [18]. The results of our first experiment suggested
that methoxyfenozide may have physiological effects in honey bees
by stimulating ISC proliferation. This observation is consistent
with the role of methoxyfenozide as an ecdysteroid agonist in the
insect midgut [52,65]. In contrast, direct feeding of 20-hydro-
xyecdysone, did not affect ISC proliferation, which may reflect the
efficient metabolic conversion of the natural hormone by the gut
[66]. Under the crowded conditions of the second experiment, the
increases in acute ISC proliferation produced by methoxyfenozide
exposure were not significant, and at the older age the low
exposure group actually showed a slightly lower number of labeled
nuclei than the respective control bees. Thus, the effect of
methoxyfenozide on the ISCs is subtle and might not have any
health consequences, particularly when considering that the
concentrations found in honey bee hives are typically lower than
the tested concentrations [18].
Fluvalinate is used by beekeepers to control Varroa and tracheal
mites. The high dosage of fluvalinate in the first experiment
proved so toxic that we quantified ISC proliferation after three
days, a time at which most of the exposed workers had already
died. At this time no significant effect on ISC proliferation was
apparent. In the second experiment we reduced the daily exposure
to the fluvalinate strip by over 80-fold, resulting in lower mortality.
No effect on ISC proliferation was found after 7 days of exposure
Figure 5. Survival of worker cohorts under high-density cage conditions was lower than in the initial screening experiment and
varied inconsistently among treatments. Different panels summarize cumulative survival of honey bee workers grouped from different cage
replicates according to the tested xenobiotic: (a) tetracycline, (b) methoxyfenozide, (c) tau-fluvalinate, and (d) the combination of tau-fluvalinate and
coumaphos. Acute mortality effects were measured during the first 7 days of exposure, while legacy mortality effects were measured on the days
after treatment had ended.
doi:10.1371/journal.pone.0091180.g005
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and 2 weeks after exposure was terminated. The second
commonly used miticide, coumaphos, also did not show significant
effects on ISC proliferation in the first experiment despite a very
high dosage only found in rare cases under natural conditions
[18,30]. However, the combination of coumaphos and fluvalinate
significantly decreased short-term ISC proliferation. Concomi-
tantly, this combination treatment decreased survivorship at all
dosage levels relative to the corresponding fluvalinate-only
treatments (log rank tests: 361 min: x2 = 15.0, p,0.001; 3 min:
x2 = 3.9, p = 0.049; 15 min: x2 = 5.9, p = 0.015). Thus, the
mortality data and ISC proliferation rates indicate synergism
between fluvalinate and coumaphos, which has been reported in
other contexts [21,22]. The dosages used in the second experiment
may be higher than average field exposure but they fall within the
limits of concentrations measured in honey bee hives [18,67] and
the findings may therefore be relevant for honey bee health.
Coumaphos and fluvalinate both target primarily the nervous
system: Coumaphos, when converted to its metabolite coumaphos
oxon, inhibits the acetylcholinesterase enzyme and fluvalinate
serves as an agonist of the voltage-gated sodium channel [22]. Our
results may therefore be explained by effects on the neural control
of the digestive system or changes in behavior that may have
indirectly decreased ISC proliferation. However, we cannot rule
out other, non-neural effects. The synergism between the two
miticides may be due to inhibition of the detoxification mechanism
[22].
We did not find support for the hypothesis that ISCs increase
proliferation to compensate for xenobiotic damage to the midgut
epithelium [37]. Instead, tetracycline and the combination of
fluvalinate and coumaphos decreased ISC proliferation, suggesting
direct or indirect effects that decrease ISC activity. The number of
labeled nuclei per active crypt also declined with age in all control
and treatment groups, except for the groups with the highest
exposure to fluvalinate. This finding confirms our earlier results
that ISC proliferation declines with age in honey bees [45]. The
age-related decline under natural conditions may reflect the fact
that digestive demand is higher in young workers, which are
typically nurse bees [45]. In our cage experiments, however,
workers did not transition from nursing to foraging behavior.
Thus, the age-related decline of ISC proliferation occurred
independently of diet or behavioral changes, suggesting the
possibility of intrinsic aging of the replicative capacity of ISCs.
Supporting Information
File S1 Significant variability in mortality among
separate cages was observed within each treatment of
the second experiment. This file details the mortality results
with respect to the separate cages in each treatment. Due to
unexplainable variation and the focus of our study on ISC
proliferation, we omitted these details from the main text.
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